The global ornithine-transcarbamylase deficiency market size was valued at USD 896.6 million in 2022 and is poised to grow at a significant CAGR of 3.4% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029.
